Mark Lansdown
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in ⓘ
-
- Breast Cancer Treatment Studies 8
-
- Parathyroid Disorders and Treatments 4
- Co-authors
- Valerie Speirs (5 shared papers)Andrew M. Hanby (3 shared papers)P J Carder (5 shared papers)Andrew Scarsbrook (2 shared papers)G. Skliris (2 shared papers)Chirag N. Patel (1 shared paper)Sally Lane (3 shared papers)Kieran Horgan (5 shared papers)
- Journals
- European Journal of Surgical Oncology (4 papers)British journal of surgery (4 papers)Human Reproduction (2 papers)Clinical Radiology (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- United KingdomItalyBelgium
In The Last Decade
Mark Lansdown
43 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 428
- Oncology 711
- Nephrology 144
- Genetics 551
- Pathology and Forensic Medicine 187
Countries citing papers authored by Mark Lansdown
This map shows the geographic impact of Mark Lansdown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lansdown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lansdown more than expected).
Fields of papers citing papers by Mark Lansdown
This network shows the impact of papers produced by Mark Lansdown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lansdown. The network helps show where Mark Lansdown may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lansdown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. | 2000 | 286 |
| 2 | 2003 | 237 | |
| 3 | 2003 | 168 | |
| 4 | 2010 | 135 | |
| 5 | 1990 | 115 | |
| 6 | 2004 | 105 | |
| 7 | 2007 | 102 | |
| 8 | 2001 | 74 | |
| 9 | Culture, attitude and knowledge about breast cancer and preventive measures: a qualitative study of South Asian breast cancer patients in the UK. | 2011 | 60 |
| 10 | 2016 | 53 | |
| 11 | 2004 | 51 | |
| 12 | 2005 | 49 | |
| 13 | 1994 | 48 | |
| 14 | 2005 | 36 | |
| 15 | 2004 | 33 | |
| 16 | 2004 | 30 | |
| 17 | 2009 | 26 | |
| 18 | 1998 | 22 | |
| 19 | 2003 | 21 | |
| 20 | 2021 | 18 |
About Mark Lansdown
Mark Lansdown is a scholar working on Cancer Research, Nephrology, Obstetrics and Gynecology, Oncology and Genetics, having authored 45 papers that have together received 1.8k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (6 papers), Thyroid and Parathyroid Surgery (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Parathyroid Disorders and Treatments (4 papers) and Global Cancer Incidence and Screening (4 papers). The work is most often cited by research in Cancer Research (428 citations), Oncology (711 citations), Nephrology (144 citations), Genetics (551 citations) and Pathology and Forensic Medicine (187 citations). Mark Lansdown has collaborated with scholars based in United Kingdom, Italy and Belgium. Frequent co-authors include Valerie Speirs, Andrew M. Hanby, P J Carder, Andrew Scarsbrook, G. Skliris, Chirag N. Patel, Sally Lane, Kieran Horgan, Timothy Perren and Ken MacLennan. Their work appears in journals such as European Journal of Surgical Oncology, British journal of surgery, Human Reproduction, Clinical Radiology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.